No Investigational Product

DRUG2 trials

Sponsors

International Partnership for Microbicides, Inc., Ultragenyx Pharmaceutical Inc

Conditions

HIV InfectionsMPS IIIAMucopolysaccharidosis IIIASanfilippo ASanfilippo Syndrome

Phase 3

Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA

Enrolling by invitationNCT04360265

Ultragenyx Pharmaceutical IncMPS IIIA, Mucopolysaccharidosis IIIA, Sanfilippo A +1

Start: 2020-09-28End: 2027-08-01Target: 41Updated: 2026-07-17

Unknown Phase

Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials

CompletedNCT01618058

International Partnership for Microbicides, Inc.HIV Infections

Start: 2012-10-04End: 2019-08-06Updated: 2019-09-06

Related Papers

Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM

Clinical Infectious Diseases2022-10-031 citations